Virginia Hughes
editor on the science desk @nytimes, focused on coronavirus treatments and vaccines. former @buzzfeednews. pro nutgraf, pro dog, anti sap. she/her.
Last synced from Twitter 1228d ago
As Election Nears, Trump Makes a Final Push Against Climate Science
The administration is imposing new limits on the National Oceanic and Atmospheric Administration that would undercut action against global warming.
1
Virginia Hughes
As Election Nears, Trump Makes a Final Push Against Climate Science
92d
Covid-19 Live Updates: A Record-Breaking Week for U.S. Virus Cases
The country has averaged at least 71,000 new coronavirus cases a day over the past week, the most in any seven-day stretch of the pandemic.
1
Virginia Hughes
New from @katie_thomas: Pfizer will not deliver vaccine results by the end of this month, its chief executive says.
92d
Covid-19 Live Updates: Surge in Hospitalizations Strains U.S. Health Care Facilities
The country has seen a 40 percent increase in the past month in the number of hospitalized Covid-19 patients.
4
Virginia Hughes
New from @katie_thomas: Eli Lilly said its antibody treatment does not work on patients hospitalized with Covid-19. It's the one Chris Christie got (tho he got it pretty early)
93d
In 2020, Hope Is Not A Given, You Have To Work For It
This has been a year of wincing and waiting for the next blow. I’ve learned that hope is best understood not as an emotion, but an orientation.
1
Virginia Hughes
Love this, @elamin88: “Among the kindest feedback we get for the newsletter is that the tone & signoff make readers feel cared for. I’ve had to, by necessity of evidence, adjust my job description in my head to include creating a small space for hope.”
95d
Schoolchildren Seem Unlikely to Fuel Coronavirus Surges, Scientists Say
Researchers once feared that school reopenings might spread the virus through communities. But so far there is little evidence that it’s happening.
1
Virginia Hughes
Schoolchildren Seem Unlikely to Fuel Coronavirus Surges, Scientists Say, by @apoorva_nyc
95d
Two Companies Restart Virus Trials in U.S. After Safety Pauses
AstraZeneca and Johnson & Johnson have restarted their late-stage trials after finding that serious illnesses in a few volunteers appeared not to be related to the vaccines.
2
Virginia Hughes
on astrazeneca trial: According to 2 experts familiar, the F.D.A. did not directly tie the vaccine to the two neurological illnesses. But the agency has advised the company to alert study volunteers about related symptoms like weakness and numbness
96d
Covid-19 Live Updates: U.S. Nears Record, With More Than 75,000 Virus Cases
The tally is the second-highest daily total since the pandemic began, as eight states set single-day case records.
1
Virginia Hughes
After pausing for safety concerns, AstraZeneca and Johnson & Johnson have resumed their U.S. vaccine trials.
96d
The Trump Administration Shut a Vaccine Safety Office Last Year. What’s the Plan Now?
The office was dedicated to the long-term safety of vaccines. Experts say plans to track coronavirus vaccines are fragmented and “behind the eight ball.”
1
Virginia Hughes
NEW from @carlzimmer: The Trump administration quietly closed a vaccine safety office last year, hampering efforts to track the long-term safety of a coronavirus vaccine.
96d
The Price for Not Wearing Masks: Perhaps 130,000 Lives
The pandemic death toll could be lowered by next spring if more Americans wear masks, a new analysis finds.
How the F.D.A. Stood Up to the President
After months of caving to pressures from the White House, Commissioner Stephen Hahn and a band of agency scientists have eked out a few victories.
3
Virginia Hughes
New: How the F.D.A. Stood Up to the President >> lots of great details here on how the vaccine guidelines got through, @BySheilaKaplan @SharonLNYT @noahweiland @maggieNYT
99d
Antibody Treatments, Though Promising, Will Be in Short Supply
All the weak points of American health care — testing delays, communication breakdowns, inequity — are working against this potential treatment.
1
Virginia Hughes
Antibody Treatments, Though Promising, Will Be in Short Supply >> @katie_thomas on just how tough it will be to get these promising drugs to the right patients
99d
A Viral Theory Cited by Health Officials Draws Fire From Scientists
A manifesto urging reliance on “herd immunity” without lockdowns was warmly received by administration officials. But the strategy cannot stem the pandemic, many experts say.
1
Virginia Hughes
A Viral Theory Cited by Health Officials Draws Fire From Scientists, report @apoorva_nyc and @SherylNYT
100d
Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial
An antiviral widely used to treat hospitalized patients did not lower the mortality rate in a multinational trial.
1
Virginia Hughes
New from @KatherineJWu and @ginakolata >> Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial
104d
Could Trump Still Spread the Coronavirus? Probably Not, Experts Say
While questions have surrounded the timing and severity of the president’s illness, health experts said he was unlikely to infect people at Thursday’s town hall event on NBC.
1
Virginia Hughes
Could Trump Still Spread the Coronavirus? Probably Not, Experts Say, by @apoorva_nyc
104d
U.S. Virus Cases Climb Toward a Third Peak
Cases are surging again after falling from a summer peak. And the spread to new areas of the country suggests the outbreak is far from over.
Trump May Be Immune to the Coronavirus. But for How Long?
A unique treatment course may have blunted his body’s production of antibodies, scientists warn.
1
Virginia Hughes
This is *fascinating* >> Trump May Be Immune to the Coronavirus. But for How Long? By @apoorva_nyc
105d
3 Covid-19 Trials Have Been Paused for Safety. That’s a Good Thing.
Experts were comforted that companies are following safety precautions. They pointed out that pauses in vaccine trials are common, but pauses in treatment trials like Eli Lilly’s are rare.
1
Virginia Hughes
New from @carlzimmer: The trial pause for Eli Lilly's antibody treatment might actually be more concerning than the pauses for the vaccine trials...something to watch for sure >>
105d
Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern
The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.
3
Virginia Hughes
More info on the Eli Lilly pause: came from a difference between treatment group and placebo group after 5 days of treatment. Could be adverse events, or just futility, says @EricTopol. They'll reassess on Oct. 26
106d
Coronavirus Reinfections Are Real but Very, Very Rare
A case in Nevada has spurred new concerns that people who have recovered from the infection may still be vulnerable. That’s unlikely, experts say.
Covid-19 Live Updates: Johnson & Johnson Halts Its Vaccine Trial
The pharmaceutical company paused the late-stage clinical trial of its coronavirus vaccine because of a sick volunteer.
2
Virginia Hughes
NEW from @KatherineJWu: Eli Lilly has paused its antibody trial due to "potential safety concerns"
106d